**Question:** The following drugs can be used for the management of status asthmaticus except-

A. Albuterol
B. Salbutamol
C. Fexofenadine
D. Prednisolone

**Core Concept:**

Status asthmaticus is a severe, potentially life-threatening condition characterized by persistent, uncontrolled airflow obstruction in asthma. Effective management requires prompt administration of bronchodilators, corticosteroids, and, in severe cases, vasodilators and intravenous corticosteroids. Each drug mentioned contributes to the management of status asthmaticus in its specific way.

**Why the Correct Answer is Right:**

Fexofenadine is a selective H1-receptor antagonist used primarily for allergic disorders like allergic rhinitis and urticaria. It is not indicated for asthma management due to its lack of bronchodilatory properties.

D. Prednisolone is a potent corticosteroid used for its anti-inflammatory and immunosuppressive effects. While it is essential in the management of asthma exacerbations, its exclusion from this list is due to its lack of direct bronchodilatory action.

**Why Each Wrong Option is Incorrect:**

A. Albuterol (Salbutamol) is a short-acting beta2-agonist that directly relaxes airway smooth muscle, leading to bronchodilation and improved airflow. It is a crucial component of status asthmaticus management.

B. Salbutamol (an albuterol analog) has similar properties to albuterol (A), acting as a short-acting beta2-agonist and providing bronchodilation for asthma management.

**Clinical Pearl:**

In treating status asthmaticus, it is essential to employ a combination of bronchodilators like albuterol and salbutamol, as well as corticosteroids for their anti-inflammatory effects and vasodilators to improve blood flow to the affected areas. Using only fexofenadine or prednisolone neglects the direct bronchodilatory effect needed for severe asthma exacerbations, potentially worsening the outcome. Always consider a multi-drug approach targeting airway inflammation, bronchoconstriction, and increased blood flow for optimal management of severe asthma exacerbations like status asthmaticus.